BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3855395)

  • 1. Cell-cycle, protein content, and nuclear size in acute myeloid leukemia.
    Ffrench M; Bryon PA; Fiere D; Vu Van H; Gentilhomme O; Adeleine P; Viala JJ
    Cytometry; 1985 Jan; 6(1):47-53. PubMed ID: 3855395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simultaneous determination of cellular DNA and proteins by cytofluorimetry. Application to acute leukemia in adults].
    Ffrench M; Fiere D; Bryon PA; Cordier G; Viala JJ
    Pathol Biol (Paris); 1984 Feb; 32(2):139-43. PubMed ID: 6366709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA, RNA, and protein content in adult acute myeloid leukemia: effects of cytostatic drugs in vivo.
    Wolowiec D; Ffrench M; Tigaud JD; Treille-Ritouet D; Archimbaud E; Bryon PA
    Leukemia; 1988 Aug; 2(8):534-9. PubMed ID: 3166079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative cytology in leukemia research.
    Barlogie B; Maddox AM; Johnston DA; Raber MN; Drewinko B; Keating MJ; Freireich EJ
    Blood Cells; 1983; 9(1):35-55. PubMed ID: 6344934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-cycle position and nuclear protein content.
    Roti Roti JL; Higashikubo R; Blair OC; Uygur N
    Cytometry; 1982 Sep; 3(2):91-6. PubMed ID: 6814878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
    Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cell cycle kinetics during induced granulocytic versus monocytic maturation of HL-60 leukemia cells.
    Ross DW
    Cancer Res; 1985 Mar; 45(3):1308-13. PubMed ID: 3855695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of flow-cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia.
    Gore SD; Weng LJ; Burke PJ
    Exp Hematol; 1993 Dec; 21(13):1702-8. PubMed ID: 7694870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A; Albright KL
    Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of HL-60 promyelocytic leukemia cells: simultaneous determination of phagocytic activity and cell cycle distribution by flow cytometry.
    Blair OC; Carbone R; Sartorelli AC
    Cytometry; 1986 Mar; 7(2):171-7. PubMed ID: 3456296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia].
    Ito M; Tsurusawa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various aspects of bone marrow cell proliferation in acute leukemia].
    Shmarov DA; Kuchma IuM; Kozinets GI
    Ter Arkh; 2001; 73(12):73-7. PubMed ID: 11858117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear protein following heat shock: protein removal kinetics and cell cycle rearrangements.
    Roti Roti JL; Uygur N; Higashikubo R
    Radiat Res; 1986 Aug; 107(2):250-61. PubMed ID: 3749460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on cell kinetics in leukemia using flow cytometry].
    Yoshida K
    Hokkaido Igaku Zasshi; 1982 Sep; 57(5):557-71. PubMed ID: 7152463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic importance of DNA histograms of bone marrow cells in acute myeloblastic leukemias].
    Janowska-Wieczorek A; Maj S; Apel D
    Acta Haematol Pol; 1981; 12(3-4):171-4. PubMed ID: 6952737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.